Search clinical trials for: Tapentadol PR

Total 259 results

Janssen Pharmaceutical K.K.
Grünenthal GmbH

Completed

Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants

Pain | Cancer

Japan
Grünenthal GmbH

Terminated

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.

Osteoarthritis | Chronic Pain

Germany, United Kingdom, Spain, Australia, Denmark, Poland
University of Alberta
McGill University; Université de Sherbrooke; University of Toronto

Completed

The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial (CoNSPiRE)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Fondazione Salvatore Maugeri

Completed

Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial

Chronic Obstructive Pulmonary Disease

Italy
Vedic Lifesciences Pvt. Ltd.

Completed

Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain

Joint Pain

India
University of Glasgow
NHS Research and Development

Completed

An Evaluation of Web Based Pulmonary Rehabilitation (webbasedPR)

Chronic Obstructive Pulmonary Disease

United Kingdom
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family Members

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Grünenthal GmbH

Completed

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics

Low Back Pain | Chronic Pain

Austria, Germany, United Kingdom, Croatia, France, Italy, Poland, Spain, Switzerland
Vedic Lifesciences Pvt. Ltd.

Completed

A Study to Evaluate the Efficacy of E-PR-01 on Musculoskeletal Health in Physically Active Individuals

Joint Pain

India
McMaster University

Recruiting

Impact of Pulmonary Rehabilitation on Loneliness in COPD

Loneliness

Canada
University of British Columbia

Completed

Sprint Snacks: The Effects of Prolonged Rest on Reduced Exertion Interval Training.

Cardiorespiratory Fitness

Canada
University Hospital, Brest

Recruiting

Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study (RAMBO)

Pulmonary Embolism | Quality of Life and Dyspnea

France
London School of Hygiene and Tropical Medicine
Wellcome Trust

Completed

Experimental Study to Assess Interventions Aimed at Improving the Equity Impact of Community-Based Health Insurance

Health Insurance

India
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Grünenthal GmbH

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects

Pharmacokinetics

Germany
Chang Gung Memorial Hospital

Unknown

Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD)

Osteoporosis | COPD,

Taiwan
University of Nebraska
National Cancer Institute (NCI); Amgen

Completed

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma

United States
Grünenthal GmbH

Completed

Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers

Pharmacokinetics

Germany
Columbia University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD (CALM)

COPD

United States
Sociedad Española de Neumología y Cirugía Torácica

Completed

Cost/Effectiveness Analysis of the Respiratory Poligraphy at Home (Telesleep)

Suspected Sleep Apnea | Daytime Sleepiness

Spain
Göteborg University

Recruiting

RCT of PR-ESSENCE - a Problem Solving Model for Youth With Challenging Behavior in Special (SiS) Treatment Homes

Neurodevelopmental Disorders | Behavior Problems

Sweden
University of Alberta
University of Calgary

Completed

Examining Pulmonary Rehabilitation on Discharged COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Amgen

Completed

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Renal Insufficiency | Multiple Myeloma

United States
Mundipharma Research GmbH & Co KG

Completed

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (HMX3501)

Constipation

Romania, Switzerland, Israel, Belgium, Germany, Australia, Austria, Czech Republic, Denmark, Finland, France, Netherlands, Poland, United Kingdom
Göteborg University

Completed

PR-ESSENCE for Youth With Challenging Behavior

Behavior Problem of Childhood and Adolescence
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain

Low Back Pain
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Effectiveness of Harmonica Playing in Improving Lung Function Among COPD Patients

COPD

China
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

Obesity | Obstructive Sleep Apnea

United States
University of Oklahoma

Active, not recruiting

Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms

Vaginal Prolapse

United States
Amgen

Completed

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Multiple Myeloma | Solid Tumors

United States, Canada
AdvanceCor GmbH
Procorde GmbH

Completed

Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion (PR-15/01)

Myocardial Infarction | Stroke | Thrombosis | Acute Coronary Syndrome

Germany
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male Volunteers

Healthy Volunteer
Janssen Research & Development, LLC

Completed

A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy

Hallux Valgus

Korea, Republic of
Proacta, Incorporated

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Proacta, Incorporated
National Cancer Institute (NCI)

Completed

PR-104 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Mayo Clinic

Recruiting

Breathing Training and Exercise Capacity in Non-CFB

Non-cystic Fibrosis Bronchiectasis

United States
Marmara University

Unknown

The Effect of Body Awareness Therapy on Postural Stability, Balance and Fear of Falling in Patients With COPD

Asthma

Turkey
Aveiro University

Completed

Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD

Pulmonary Disease, Chronic Obstructive
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg Tablet

Healthy Volunteer
Grünenthal GmbH
Depomed

Completed

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Acute Pain

United States, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Poland, Spain, United Kingdom
Grünenthal GmbH

Completed

Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women

Prolonged QTc Interval | Pharmacokinetic

Germany
Janssen Pharmaceutica

Withdrawn

A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain

Moderate to Severe Chronic Non-cancer Pain
Mundipharma Research GmbH & Co KG

Completed

A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects

Severe Chronic Pain

Germany
Grünenthal GmbH

Completed

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin

Low Back Pain | Neuropathic Pain

Austria, Belgium, Denmark, Germany, Netherlands, Poland, Spain
Villa Pineta Hospital
University of Modena and Reggio Emilia

Completed

Efficacy of Arm Training in COPD Patients (UEET-COPD)

Pulmonary Disease, Chronic Obstructive

Italy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet

Healthy

United States
Amgen

Completed

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Multiple Myeloma

United States, Canada
Janssen-Cilag International NV
Grünenthal GmbH

Completed

A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo

Hallux Valgus

Taiwan
Aretaieion University Hospital

Recruiting

Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery (vasso-annie)

Pain, Postoperative | Postoperative Pain | Analgesia | Surgery | Pain, Acute | Pain, Procedural | Pain, Chronic | Pain, Neuropathic

Greece
Amgen

Completed

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada

Search clinical trials for: Tapentadol PR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations